Regenerative medicine company Orthocell (ASX:OCC) has appointed Komak Sp as its exclusive distributor of CelGro for dental bone and soft tissue repair across Poland.
“Komak is a leading distributor of innovative medical devices with an experienced team to assist in managing the promotion and distribution of CelGro.” said managing director of Orthocell, Paul Anderson.
“Komak is the ideal partner in this important emerging market with established relationships with dental and orthopaedic surgeons and a successful track record driving market entry of high quality products.”
The distributor agreement follows the appointment of Bimar Ortho in Italy and the company said it is consistent with its strategy to expand the network of specialised distributors in key markets within Europe.
Komak will lead the distribution of Orthocell’s CelGro for dental bone and soft tissue repair across Poland undertaking targeted promotion activities, initiating sales, as well as expanding the network of referring periodontists and oral and maxillofacial surgeons.
"The exclusive distribution agreement has a term of five years and enables Orthocell access to an attractive emerging market, with a rapid uptake of innovative medical devices and a growing healthcare expenditure per capita," said the company.
Managing Director of Komak, Tomir Kosowski, said: “Our goal is to bring innovative products of the highest quality, from around the world to Poland and we are excited for CelGro to form a part of the groundbreaking suite of medical devices we distribute.”